Cargando…

Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice

BACKGROUND: The purpose of this study was to explore the function and mechanism of peroxisome proliferator activated receptor agonist (PPARγ) in the toll-like receptor 2 (TLR2)/nod-like receptor with pyrin domain containing 3 (NLRP3) inflammatory corpuscle pathway of asthmatic mice. MATERIAL/METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yinzhi, Li, Shuai, Wang, Muzi, Cheng, Cheng, Liu, Rongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Animal Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301258/ https://www.ncbi.nlm.nih.gov/pubmed/30544130 http://dx.doi.org/10.12659/MSM.910766

Ejemplares similares

A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome
por: Hu, Jian, et al.
Publicado: (2017)

Increased Expression of the NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome in Dermatomyositis and Polymyositis is a Potential Contributor to Their Pathogenesis
por: Yin, Xi, et al.
Publicado: (2016)

Role of the thioredoxin interacting protein in diabetic nephropathy and the mechanism of regulating NOD-like receptor protein 3 inflammatory corpuscle
por: Gu, Chunmei, et al.
Publicado: (2019)

Baicalin Inhibits NOD-Like Receptor Family, Pyrin Containing Domain 3 Inflammasome Activation in Murine Macrophages by Augmenting Protein Kinase A Signaling
por: Li, Chen-Guang, et al.
Publicado: (2017)

Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis
por: Mai, Weijian, et al.
Publicado: (2020)

Hepatitis E virus infection activates NOD‐like receptor family pyrin domain‐containing 3 inflammasome antagonizing interferon response but therapeutically targetable
por: Li, Yang, et al.
Publicado: (2021)

Effect and mechanism of reactive oxygen species-mediated NOD-like receptor family pyrin domain-containing 3 inflammasome activation in hepatic alveolar echinococcosis
por: Chen, Cai-Song, et al.
Publicado: (2023)

Significance of elevated serum and hepatic NOD-like receptor pyrin domain containing 3 (NLRP3) in hepatitis C virus-related liver disease
por: Aggan, Hoda El, et al.
Publicado: (2022)

NOD-Like Receptor Protein 3 Inflammasome Priming and Activation in Barrett’s Epithelial Cells
por: Nadatani, Yuji, et al.
Publicado: (2016)

Genotype–phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients
por: Yoganathan, Priyatharsan, et al.
Publicado: (2021)

Comparative evaluation of the levels of nod-like receptor family pyrin domain-containing protein (NLRP) 3 in saliva of subjects with chronic periodontitis and healthy controls
por: Mitra, Dipika Kalyan, et al.
Publicado: (2022)

Vitamin D Status Modestly Regulates NOD-Like Receptor Family with a Pyrin Domain 3 Inflammasome and Interleukin Profiles among Arab Adults
por: Yakout, Sobhy M., et al.
Publicado: (2023)

Toll-like receptors and NOD-like receptors in rheumatic diseases
por: McCormack, William J, et al.
Publicado: (2009)

NOD-like receptors and inflammation
por: Mathews, Rebeccah J, et al.
Publicado: (2008)

NOD-like receptors in asthma
por: Alvarez-Simon, Daniel, et al.
Publicado: (2022)

Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma
por: BO, QI-FU, et al.
Publicado: (2015)

Molecular mechanism of benign biliary stricture inhibition by rosiglitazone-activated peroxisome proliferator-activated receptor gamma
por: Jiamei, Lu, et al.
Publicado: (2022)

NOD-Like Receptors in Lung Diseases
por: Chaput, Catherine, et al.
Publicado: (2013)

NOD-Like Receptor Signaling in Cholesteatoma
por: Leichtle, Anke, et al.
Publicado: (2015)

The time course of nod-like receptor family pyrin domain containing 3 inflammasome complex expressions in the testis tissue of an experimental varicocele rat model: An experimental study
por: Fallah Asl, Hamideh, et al.
Publicado: (2023)

Nod-Like Receptor Pyrin-Containing Protein 6 (NLRP6) Is Up-regulated in Ileal Crohn’s Disease and Differentially Expressed in Goblet Cells
por: Ranson, Nicole, et al.
Publicado: (2018)

Structure of fish Toll-like receptors (TLR) and NOD-like receptors (NLR)
por: Sahoo, Bikash Ranjan
Publicado: (2020)

Role of toll-like receptors and nod-like receptors in acute lung infection
por: Le, John, et al.
Publicado: (2023)

Innate immunity receptors in depression and suicide: upregulated NOD-like receptors containing pyrin (NLRPs) and hyperactive inflammasomes in the postmortem brains of people who were depressed and died by suicide
por: Pandey, Ghanshyam N., et al.
Publicado: (2021)

The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson’s disease
por: Wang, Jing, et al.
Publicado: (2021)

The role of Nod-like receptor protein 3 inflammasome activated by ion channels in multiple diseases
por: Xu, Xiaolin, et al.
Publicado: (2022)

Long noncoding RNA maternally expressed gene 3 improves trophoblast dysfunction and inflammation in preeclampsia through the Wnt/β-Catenin/nod-like receptor pyrin domain-containing 3 axis
por: Liang, Yue, et al.
Publicado: (2022)

Activation and regulation mechanisms of NOD-like receptors based on structural biology
por: Ohto, Umeharu
Publicado: (2022)

Activation of the High Mobility Group Box 1/Receptor for Advanced Glycation Endproducts /NOD‐like Receptor Family Pyrin Domain‐Containing 3 Axis Under Chronic Intermittent Hypoxia Induction Promotes the Progression of Atherosclerosis in ApoE (−/−) Mice
por: Tan, Haoqu, et al.
Publicado: (2023)

Functions of NOD-Like Receptors in Human Diseases
por: Zhong, Yifei, et al.
Publicado: (2013)

Licensing Adaptive Immunity by NOD-Like Receptors
por: Liu, Dong, et al.
Publicado: (2013)

NOD-Like Receptors in Infection, Immunity, and Diseases
por: Kim, Young Keun, et al.
Publicado: (2016)

Diversity and Variability of NOD-Like Receptors in Fungi
por: Dyrka, Witold, et al.
Publicado: (2014)

The role of NOD-like receptors in innate immunity
por: Almeida-da-Silva, Cássio Luiz Coutinho, et al.
Publicado: (2023)

Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
por: Yang, Soo Jin, et al.
Publicado: (2011)

The Evolving Role of Nucleotide-binding Oligomerisation Domain-like Receptor Pyrin Domain 3 Inflammasome Activation in Vascular Endothelial Cells: A Review
por: ABAS, Razif, et al.
Publicado: (2022)

Crosstalk between Peroxisome Proliferator-Activated Receptors and Toll-Like Receptors: A Systematic Review
por: Dana, Nasim, et al.
Publicado: (2019)

Interference with lysophosphatidic acid receptor 5 ameliorates oxidized low-density lipoprotein-induced human umbilical vein endothelial cell injury by inactivating NOD-like receptor family, pyrin domain containing 3 inflammasome signaling
por: Xu, Ling, et al.
Publicado: (2021)

Association between Nod-like receptor protein 3 inflammasome and gouty nephropathy
por: Zhang, Yan-Zi, et al.
Publicado: (2020)

Inhibition of the NOD-Like Receptor Protein 3 Inflammasome Is Protective in Juvenile Influenza A Virus Infection
por: Coates, Bria M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iuldeticr2subu234i6ckkjbmq